Vitamin D
Also called: calciferol, cholecalciferol, vitamin D3, ergocalciferol, vitamin D2
A fat-soluble vitamin present in few foods and made in skin exposed to UV light. The liver converts it to 25-hydroxyvitamin D and the kidneys to active calcitriol. Sources include fatty fish, fish liver oils, egg yolks, UV-treated mushrooms and fortified milk and cereals.
- Category
- Vitamin
- Forms
- Vitamin D3 (cholecalciferol); vitamin D2 (ergocalciferol)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2019 meta-analysis (JAMA Netw Open) pooled 11 RCTs (34,243 participants) of vitamin D supplementation alone (400-30,000 IU, daily or intermittent) for fracture; trials combining vitamin D with calcium were analyzed separately. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BCancer2 topics
XBrain, mood and sleep1 topic
XHeart and blood vessels1 topic
XBlood sugar and weight1 topic
XBones and joints1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Cancer incidence | X | VITAL (25,871 adults; 2,000 IU/day D3; median 5.3 years) found no significant difference in breast, prostate or colorectal cancer; ODS states studies do not show supplementation reduces cancer incidence. [1] |
| Cancer mortality | B | Three meta-analyses of clinical trials found supplementation reduced total cancer mortality by 12% to 13%; the most recent (10 trials) found the benefit greatest with daily dosing. [1] |
| Cardiovascular disease | X | In VITAL (25,871 adults; 2,000 IU/day; median 5.3 years), vitamin D did not significantly reduce heart attacks, strokes, coronary revascularization or cardiovascular deaths. [1] |
| Fractures and falls in older adults | X | A VITAL ancillary study (25,871 participants) found no lower risk of total, hip or nonvertebral fractures; the USPSTF concluded with moderate certainty supplementation does not reduce falls in adults 65+. [1] |
| Type 2 diabetes in prediabetes | X | A trial in 2,423 adults with prediabetes and overweight or obesity (4,000 IU/day D3, median 2.5 years) found no significant reduction in diabetes versus placebo. [1] |
| Depression | X | In VITAL (16,657 participants without depression history; 1,696 at increased risk), there were no significant differences in depression incidence, recurrence, symptoms or mood scores. [1] |
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- RDA: adults 19–70 years 15 mcg (600 IU); adults over 70 years 20 mcg (800 IU); pregnancy and lactation 15 mcg (600 IU). [1]
- Trial amounts: 50 mcg (2,000 IU)/day vitamin D3 (VITAL); 100 mcg (4,000 IU)/day vitamin D3 (prediabetes trial). [1]
Upper limits
- UL, adults 19+ (including pregnancy and lactation): 100 mcg (4,000 IU)/day. ODS notes that intakes below the UL could also cause harm over time. [1]
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated 2021-05-27: neither normal nor excessively high …
Details and sources - Pregnancy and breastfeedingRDA 15 mcg (600 IU) and UL 100 mcg (4,000 IU) in pregnancy and lactation.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Orlistat; Statins, steroids, thiazide diuretics
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications7 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Excess vitamin D, almost always from supplements, can cause hypercalcemia, leading to nausea, vomiting, muscle weakness, neuropsychiatric disturbances, pain and kidney stones; extreme cases can cause kidney failure, soft-tissue calcification, arrhythmias and death. [1]
- Toxicity is marked by serum 25(OH)D typically above 375 nmol/L (150 ng/mL); the Food and Nutrition Board recommended avoiding levels above approximately 125 to 150 nmol/L (50–60 ng/mL). [1]
- Groups at risk of inadequacy: breastfed infants, older adults, people with limited sun exposure or darker skin, people with fat malabsorption or obesity, and people who have had gastric bypass surgery. [1]
Interactions
| With | What happens |
|---|---|
| Orlistat | Together with a reduced-fat diet, can reduce vitamin D absorption and lower 25(OH)D levels. [1] |
| Statins (atorvastatin, lovastatin, simvastatin) | Statins may reduce vitamin D synthesis; high vitamin D intakes, especially from supplements, might reduce the potency of these statins, which share a metabolizing enzyme. [1] |
| Corticosteroids (e.g., prednisone) and thiazide diuretics | Listed by ODS among medications that can interact with vitamin D; discuss vitamin D use with the prescriber. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Supplements contain D2 (ergocalciferol) or D3 (cholecalciferol). Both are well absorbed, but D3 raises serum 25(OH)D more and maintains higher levels longer than D2. [1]
Regulatory status
- US: available in dietary supplements; milk, breakfast cereals and plant milks are commonly fortified. The FDA Daily Value is 20 mcg (800 IU). [1]
- The USPSTF found evidence insufficient to assess supplementation for fracture prevention in adults 50+ and recommended against 10 mcg (400 IU) or less of vitamin D with 1,000 mg or less of calcium for this purpose. [1]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol), which differ chemically only in their side-chain structures Fat-soluble vitamin (calciferols) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 7 entries naming vitamin D or cholecalciferol (five as part of multi-ingredient products) (earliest NDI 286 submitted 2004-04-14; most recent NDI 868 submitted 2015-04-20). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
- A separate entry, NDI 945 (submitted 2016-09-08), names 25-hydroxycholecalciferol (calcifediol). [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of vitamin D (cholecalciferol or ergocalciferol) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
- NTP technical reports list checked 2026-10-29: no study of vitamin D (cholecalciferol or ergocalciferol). [P4]
Liver (NIH LiverTox)
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated 2021-05-27: neither normal nor excessively high intakes are associated with liver injury; toxicity is from hypercalcemia. [P5]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) for every dietary-ingredient component; an exemption may be requested by petition under 21 CFR 10.30. [P6]
- Vitamin D content (potency) assay — LiverTox names mislabeling of over-the-counter or locally prepared supplements, excessive fortification and dispensing errors as common causes of hypervitaminosis D. [P5]
Supply and conservation
- Vitamin D2 is manufactured using UV irradiation of ergosterol in yeast; vitamin D3 is typically produced by irradiating 7-dehydrocholesterol from lanolin obtained from sheep's wool; an animal-free vitamin D3 sourced from lichen is also available. [P1]
Absorption in people
- Both D2 and D3 are well absorbed in the small intestine; fat in the gut enhances absorption, but some is absorbed without dietary fat; neither aging nor obesity alters absorption. Most evidence indicates D3 raises serum 25(OH)D more and maintains higher levels longer than D2. Per microgram, 25(OH)D3 is three to five times as potent as vitamin D3. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- RDA 15 mcg (600 IU) and UL 100 mcg (4,000 IU) in pregnancy and lactation. Human milk provides less than 0.6 to 2.0 mcg/L (25 to 78 IU/L), and levels are higher in mothers taking at least 50 mcg (2,000 IU) vitamin D3. [P1]
Sources for this profile
- NIH Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals (no update date shown on page; accessed 2026-10-29), 2026-10-29. ods.od.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. Agents Classified by the IARC Monographs: List of Classifications (accessed 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (accessed 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Vitamin D (Last Update: 2021-05-27), 2021-05-27. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- NIH Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals (no 'updated' date shown; page last modified October 22, 2026), 2026-10-22. ods.od.nih.gov
- Yao P, et al. Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis. JAMA Netw Open 2019;2(12):e1917789 (PMID 31860103), 2019-12-02. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.